Article info

PDF

Extended report
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Authors

  1. Correspondence to Dr Hermine I Brunner, Cincinnati Children's Hospital Medical Center, Division of Rheumatology and the Anderson Center for Excellence in Health Care, PRCSG Coordinating Center, MC 4010, 3333 Burnet Avenue, Cincinnati, OH 45229-3930, USA; Hermine.brunner{at}cchmc.org
View Full Text

Citation

Brunner HI, Ruperto N, Zuber Z, et al
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Publication history

  • Received February 4, 2014
  • Revised April 10, 2014
  • Accepted April 16, 2014
  • First published May 16, 2014.
Online issue publication 
May 08, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.